Used in peptide synthesis as a protected amino acid building block, enabling the incorporation of a morpholine-modified alanine residue into peptide chains. The Fmoc group allows for mild base deprotection in solid-phase synthesis, making it compatible with standard Fmoc/tBu strategies. The morpholine side chain can influence peptide solubility and may participate in hydrogen bonding or metal coordination, useful in designing bioactive peptides or peptidomimetics. Commonly applied in medicinal chemistry for developing protease inhibitors, receptor ligands, or functional probes where structural diversity and polarity are important.